Response to Smallpox Vaccine in Persons Immunized in the Distant Past

JAMA

Volumn 289, Issue 24, 2003, Pages 3295-3299

  Frey, Sharon E ^a,c   Newman, Frances K ^a   Yan, Lihan ^b   Belshe, Robert B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMMES CORPORATION   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; SMALLPOX VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; MALE; NORMAL HUMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROPHYLAXIS; PUSTULE; RANDOMIZATION; REVACCINATION; SHOULDER; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN MANIFESTATION; SMALLPOX; VACCINIA VIRUS; VIRUS SHEDDING; BLOOD; ERYTHEMATOSQUAMOUS SKIN DISEASE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MIDDLE AGED; SINGLE-BLIND METHOD; SKIN DISEASES, PAPULOSQUAMOUS; SMALLPOX VACCINE; VACCINATION; VACCINIA VIRUS; VIRUS SHEDDING;

EID: 0038167797     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.24.3295     Document Type: Article

References (12)

1. Henderson DA. The looming threat of bioterrorism. Science. 1999;283:1279-1282.
2. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265-1274.
3. Lane JM, Mack TM, Millar JD. Take rates by double versus single insertions of smallpox vaccine in revaccinees. Public Health Rep. 1970;85:928-932.
4. Polak MF, Horsman J, Bos JM, Hekker AC. Cutaneous responses to smallpox revaccination with calf lymph and the effect of fluorocarbon purification of the vaccine. Bull World Health Organ. 1972;47:185-194.
5. Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med. 2002;346: 1275-1280.
6. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep. 2001;50(RR-10):1-25.
7. Newman FK, Frey SE, Blevins TP, Yan L, Belshe RB. Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax. J Infect Dis. 2003;187:1319-1320.
8. Graham BS, Belshe RB, Clements ML, et al. Vaccination of vaccinia-naïve adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. J Infect Dis. 1992;166:244-252.
9. Newman FK, Frey SE, Blevins TP, et al. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. In press.
10. Iacono-Connors LC, Novak J, Rossi C, Mangiafico J, Ksiasek T. Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies. Clin Diagn Lab Immunol. 1994;1:78-82.
11. Holander M, Wolfe D. Nonparametric Statistical Considerations. New York, NY; Wiley; 1973;115-116.
12. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc; 1999.